Compare Enveric Biosciences Inc (ENVB) vs Modine Manufacturing Company (MOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Modine Manufacturing Company — how do they compare? Enveric Biosciences Inc trades at $1.37 (market cap $5.32M), while Modine Manufacturing Company trades at $226.12 (market cap $12.32B). The key difference: Modine Manufacturing Company is far larger — about 2315.8× Enveric Biosciences Inc's market cap, and Modine Manufacturing Company is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | MOD | |
|---|---|---|
Market Cap | $5.32M | $12.32B |
Sector | Health | Technology |
52-Week High | $17.40 | $306.89 |
52-Week Low | $1.28 | $91.30 |
Enterprise Value | $408.82K | $12.68B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
Modine (MOD) trades at $230.04, up 0.2% with a bearish technical signal despite strong analyst consensus. The company has consistently beaten earnings estimates in recent quarters, with Q2 2026 results pending. Financials show solid revenue growth to $2.58B in 2025 but declining profit margins. The stock faces technical headwinds with key support at $225 and resistance at $235.
Modine presents a mixed outlook with strong analyst support (76.9% buy ratings) and a $328.80 price target suggesting 43% upside. However, declining profit margins and bearish technical indicators create near-term uncertainty. The data center business expansion offers growth potential, but execution risks and competitive pressures remain key challenges for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Modine Manufacturing Company
Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →
